One Day Later

Por Van Allen, Eliezer M.
Publicado em 2010

Next-generation sequencing to guide cancer therapy

Por Gagan, Jeffrey, Van Allen, Eliezer M.
Publicado no Genome Med (2015)

Precision medicine for advanced prostate cancer

Por Mullane, Stephanie A., Van Allen, Eliezer M.
Publicado no Curr Opin Urol (2016)

Delivering on the promise of precision cancer medicine

Por Berger, Michael F., Van Allen, Eliezer M.
Publicado no Genome Med (2016)

Clinical Analysis and Interpretation of Cancer Genome Data

Por Van Allen, Eliezer M., Wagle, Nikhil, Levy, Mia A.
Publicado no J Clin Oncol (2013)

Genomic Approaches to Understanding Response and Resistance to Immunotherapy

Por Braun, David A., Burke, Kelly P, Van Allen, Eliezer M.
Publicado no Clin Cancer Res (2016)

Off-Label Use of Rituximab in a Multipayer Insurance System

Por Van Allen, Eliezer M., Miyake, Todd, Gunn, Nathan, Behler, Caroline M., Kohlwes, Jeff
Publicado em 2011

A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition

Por Whittaker, Steven R., Theurillat, Jean-Philippe, Van Allen, Eliezer, Wagle, Nikhil, Hsiao, Jessica, Cowley, Glenn S., Schadendorf, Dirk, Root, David E., Garraway, Levi A.
Publicado em 2013

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

Por Nathanson, Tavi, Ahuja, Arun, Rubinsteyn, Alexander, Aksoy, Bulent Arman, Hellmann, Matthew D., Miao, Diana, Van Allen, Eliezer, Merghoub, Taha, Wolchok, Jedd, Snyder, Alexandra, Hammerbacher, Jeff
Publicado no Cancer Immunol Res (2016)

Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors

Por Kim, Jaegil, Mouw, Kent W, Polak, Paz, Braunstein, Lior Z, Kamburov, Atanas, Kwiatkowski, David J, Rosenberg, Jonathan E, Van Allen, Eliezer M, D'Andrea, Alan, Getz, Gad
Publicado no Nat Genet (2016)

Genetic effect of chemotherapy exposure in children of testicular cancer survivors

Por Kryukov, Gregory V., Bielski, Craig M., Samocha, Kaitlin, Fromer, Menachem, Seepo, Sara, Gentry, Carleen, Neale, Benjamin, Garraway, Levi A., Sweeney, Christopher, Taplin, Mary-Ellen, Van Allen, Eliezer M.
Publicado no Clin Cancer Res (2015)

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothe...

Por Bellmunt, Joaquim, Werner, Lillian, Leow, Jeffrey J., Mullane, Stephanie A., Fay, André P., Riester, Markus, Van Hummelen, Paul, Taplin, Mary-Ellen, Choueiri, Toni K., Van Allen, Eliezer, Rosenberg, Jonathan
Publicado no PLoS One (2015)

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine

Por Van Allen, Eliezer M., Robinson, Dan, Morrissey, Colm, Pritchard, Colin, Imamovic, Alma, Carter, Scott, Rosenberg, Mara, McKenna, Aaron, Wu, Yi-Mi, Cao, Xuhong, Chinnaiyan, Arul, Garraway, Levi, Nelson, Peter S.
Publicado no Oncotarget (2016)

Tumor mutational load and immune parameters across metastatic Renal Cell Carcinoma (mRCC) risk groups

Por de Velasco, Guillermo, Miao, Diana, Voss, Martin H., Hakimi, A. Ari, Hsieh, James J., Tannir, Nizar M., Tamboli, Pheroze, Appleman, Leonard J., Rathmell, W. Kimryn, Van Allen, Eliezer M., Choueiri, Toni K.
Publicado no Cancer Immunol Res (2016)

Kinome wide functional screen identifies role of Polo-like kinase 1 (PLK1) in hormone-independent, ER-positive breast cancer

Por Bhola, Neil, Jansen, Valerie M., Bafna, Sangeeta, Giltnane, Jennifer M., Balko, Justin M., Estrada, Mónica V., Meszoely, Ingrid, Mayer, Ingrid, Abramson, Vandana, Ye, Fei, Sanders, Melinda, Dugger, Teresa C., Van Allen, Eliezer, Arteaga, Carlos L.
Publicado no Cancer Res (2014)

A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record

Por Tarczy-Hornoch, Peter, Amendola, Laura, Aronson, Samuel J., Garraway, Levi, Gray, Stacy, Grundmeier, Robert W., Hindorff, Lucia A., Jarvik, Gail, Karavite, Dean, Lebo, Matthew, Plon, Sharon E., Van Allen, Eliezer, Weck, Karen E., White, Peter S., Yang, Yaping
Publicado em 2013

PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration Resistant Prostate Cancer, is a Mediator of Resistance to Androgen Deprivation Therapy

Por Hsieh, Chen-Lin, Botta, Ginevra, Gao, Shuai, Li, Tiantian, Van Allen, Eliezer M., Treacy, Daniel J., Cai, Changmeng, He, Housheng Hansen, Sweeney, Christopher J., Brown, Myles, Balk, Steven P., Nelson, Peter S., Garraway, Levi A., Kantoff, Philip W.
Publicado no Cancer Res (2015)

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

Por Tolaney, Sara M., Tan, Sally, Guo, Hao, Barry, William, Van Allen, Eliezer, Wagle, Nikhil, Brock, Jane, Larrabee, Katherine, Paweletz, Cloud, Ivanova, Elena, Janne, Pasi, Overmoyer, Beth, Wright, John J., Shapiro, Geoffrey I., Winer, Eric P., Krop, Ian E.
Publicado no Invest New Drugs (2015)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)

Por Powles, Thomas, Nickles, Dorothee, Van Allen, Eliezer, Chappey, Colombe, Zou, Wei, Kowanetz, Marcin, Kadel, Edward, Denker, Mitchell, Boyd, Zachary, Vogelzang, Nicholas, Kim, Joseph, Bellmunt, Joaquim, Loriot, Yohann, Drake, Charles G, O'Hear, Carol, Fasso, Marcella, Hegde, Priti, Mariathasan, Sanjeev
Publicado no J Immunother Cancer (2015)

Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study

Por Gray, Stacy W., Park, Elyse R., Najita, Julie, Martins, Yolanda, Traeger, Lara, Bair, Elizabeth, Gagne, Joshua, Garber, Judy, Jänne, Pasi A., Lindeman, Neal, Lowenstein, Carol, Oliver, Nelly, Sholl, Lynette, Van Allen, Eliezer M., Wagle, Nikhil, Wood, Sam, Garraway, Levi, Joffe, Steven
Publicado no Genet Med (2016)